Ahter Dilsad Sanlioglu
Ahter Dilsad Sanlioglu
Tıbbi Biyoloji ve Genetik Profesörü, Akdeniz Üniversitesi
akdeniz.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells
AD Sanlioglu, E Dirice, C Aydin, N Erin, S Koksoy, S Sanlioglu
BMC cancer 5 (1), 54, 2005
1232005
The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma
IT Koksal, E Dirice, D Yasar, AD Sanlioglu, A Ciftcioglu, KH Gulkesen, ...
Urologic Oncology: Seminars and Original Investigations 22 (4), 307-312, 2004
612004
TRAIL Death Receptor–4 Expression Positively Correlates With the Tumor Grade in Breast Cancer Patients With Invasive Ductal Carcinoma
AD Sanlioglu, AF Korcum, E Pestereli, G Erdogan, S Karaveli, B Savas, ...
International Journal of Radiation Oncology* Biology* Physics 69 (3), 716-723, 2007
562007
DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells
AD Sanlioglu, B Karacay, IT Koksal, TS Griffith, S Sanlioglu
Cancer gene therapy 14 (12), 976-984, 2007
512007
Differential expression of TRAIL and its receptors in benign and malignant prostate tissues
AD Sanlioglu, IT Koksal, A Ciftcioglu, M Baykara, G Luleci, S Sanlioglu
The Journal of urology 177 (1), 359-364, 2007
472007
Adenovirus-mediated IKK β KA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis
AD Sanlioglu, IT Koksal, B Karacay, M Baykara, G Luleci, S Sanlioglu
Cancer Gene Therapy 13 (1), 21-31, 2006
462006
High TRAIL death receptor 4 and decoy receptor 2 expression correlates with significant cell death in pancreatic ductal adenocarcinoma patients
AD Sanlioglu, E Dirice, O Elpek, AF Korcum, M Ozdogan, I Suleymanlar, ...
Pancreas 38 (2), 154-160, 2009
432009
Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma
AD Sanlioglu, C Aydin, H Bozcuk, E Terzioglu, S Sanlioglu
Lung Cancer 44 (2), 199-211, 2004
412004
Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis
E Terzioglu, A Bisgin, AD Sanlioglu, M Ulker, V Yazisiz, S Tuzuner, ...
Rheumatology 46 (5), 783-789, 2007
402007
Clinical utility of insulin and insulin analogs
AD Sanlioglu, HA Altunbas, MK Balci, TS Griffith, S Sanlioglu
Islets 5 (2), 67-78, 2013
392013
Therapeutic potential of VIP vs PACAP in diabetes
AD Sanlioglu, B Karacay, MK Balci, TS Griffith, S Sanlioglu
Journal of molecular endocrinology 49 (3), R157-R167, 2012
382012
Adenovirus-mediated TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets prolongs normoglycemia in streptozotocin-induced diabetic rats
E Dirice, AD Sanlioglu, S Kahraman, S Ozturk, MK Balci, A Omer, ...
Human gene therapy 20 (10), 1177-1189, 2009
372009
Decoy receptor-2 small interfering RNA (siRNA) strategy employing three different siRNA constructs in combination defeats adenovirus-transferred tumor necrosis factor-related …
C Aydin, AD Sanlioglu, B Karacay, G Ozbilim, L Dertsiz, O Ozbudak, ...
Human gene therapy 18 (1), 39-50, 2007
372007
Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased …
IT Koksal, AD Sanlioglu, B Karacay, TS Griffith, S Sanlioglu
Urologic Oncology: Seminars and Original Investigations 26 (2), 158-165, 2008
362008
Molecular mechanisms of death ligand‐mediated immune modulation: A gene therapy model to prolong islet survival in type 1 diabetes
AD Sanlioglu, TS Griffith, A Omer, E Dirice, R Sari, HA Altunbas, MK Balci, ...
Journal of cellular biochemistry 104 (3), 710-720, 2008
322008
Molecular analysis of beta-thalassemia and sickle cell anemia in Antalya
I Keser, AD Sanlioglu, E Manguoglu, OG Kayisli, N Nal, F Sargin, ...
Acta haematologica 111 (4), 205-210, 2004
312004
NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL
C Aydin, AD Sanlioglu, A Bisgin, B Yoldas, L Dertsiz, B Karacay, ...
BMC cancer 10 (1), 584, 2010
282010
High levels of endogenous tumor necrosis factor-related apoptosis-inducing ligand expression correlate with increased cell death in human pancreas
AD Sanlioglu, E Dirice, O Elpek, AF Korcum, MK Balci, A Omer, TS Griffith, ...
Pancreas 36 (4), 385-393, 2008
282008
Association of circulating sTRAIL and high-sensitivity CRP with type 2 diabetic nephropathy and foot ulcers
HO Arık, AD Yalcin, S Gumuslu, GE Genç, A Turan, AD Sanlioglu
Medical science monitor: international medical journal of experimental and …, 2013
272013
Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer
U Mert, AD Sanlioglu
Cellular and Molecular Life Sciences 74 (2), 245-255, 2017
232017
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20